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Mechanism of the Attenuated Peak Heart Rate Response to Exercise
After Orthotopic Cardiac Transplantation
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MARK A. CREAGER, MD, FACC, L . HOWARD HARTLEY, MD, FACC,
WILSON S . COLUCCI, MD, FACC
Boston, Massachusetts
The mechanism responsible for attenuation of the peak
heart rate response to exercise in patients after cardiac
transplantation was studied . Because the donor heart is
believed to be surgically denervated, the peak heart rate
response to exercise is dependent primarily on 1) an in-
crease in the circulating levels of the catecholamines nor-
epinephrine and epinephrine at peak exercise, and ) the
end-organ responsiveness of the sinoatrial (SA) node to
beta-adrenergic stimulation . To assess the former mecha-
nism, the levels of plasma nonepinephrine and epinephrine
were measured at rest and at peak exercise on a cycle
ergometer in 3 transplant recipients an average of 7 ± 1
months after transplantation and in 3 normal subjects
matched for age . To assess the latter mechanism, the heart
rate response to a graded infusion of isoproterenol was
determined in six normal subjects with and without atro-
pine pretreatment and in eight transplant recipients .
After orthotopic cardiac transplantation, the heart rate re-
sponse to exercise is delayed, most likely because of the lack
of cardiac innervation (1, ) . In addition, the peak heart rate
achieved in response to a maximal exercise effort is also
reduced, even years after transplantation (1, ) . In normal
subjects, heart rate increases early in exercise because of
withdrawal of parasympathetic tone (3) . The further increase
in heart rate at maximal exercise effort is dependent on
increased sympathetic stimulation of the sinoatrial (SA)
node (3) . Thus, in normal subjects, the maximal heart rate
achieved with exercise is the consequence of the level of
sympathetic stimulation of the heart and the functional
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In transplant recipients, both the absolute plasma levels
of nonepinephrine and epinephrine at peak exercise and the
increments from baseline to peak exercise were comparable
with or greater than those in normal subjects . In transplant
recipients, the isoproterenol dose that increased heart rate
by 5 beats/min over baseline was not different from that in
atropine-treated normal subjects (normal subjects 9 ±
ng/kg per min; transplant recipients 11 ± I ng/kg per min ;
p = NS) .
These data show that after cardiac transplantation,
there is a normal or slight elevation of circulating catechol-
amines at peak exercise, and that the responsiveness of the
SA node to beta-adrenergic stimulation is normal . Thus,
the most likely explanation for the attenuated peak heart
rate response to exercise after cardiac transplantation is
lack of direct efferent innervation of the SA node .
(J Am Coll Cardiol 1989;14:338-44)
integrity of the beta-adrenergic receptor pathway in the SA
node. After cardiac transplantation, the donor heart is sur-
gically denervated and, therefore, without efferent parasym-
pathetic or sympathetic innervation (1) . Consequently, the
heart rate at rest after cardiac transplantation is elevated as
a result of the loss of parasympathetic tone, and a further
increase in heart rate can be mediated only by an increase in
circulating catecholamines (1) .
The mechanism responsible for the reduced peak heart
rate response to exercise in patients after orthotopic cardiac
transplantation is not known . There are at least three poten-
tial mechanisms : 1) a decrease in the rise in circulating
catecholamines in response to exercise, ) an abnormality in
beta-adrenergic receptor function at the level of the SA
node, or 3) a lack of direct cardiac sympathetic innervation
as a result of surgical denervation . In this study, the first two
of these mechanisms are examined . The adequacy of the
circulating catecholamine response to exercise was evalu-
ated by measuring the changes in plasma norepinephrine and
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Table 1 . Characteristics of 3 Normal Subjects and 3 Transplant Recipients Who Underwent
Exercise Testing
F = female ; M = male : N/A = not applicable .
epinephrine levels during exercise in 3 patients 7 ± I
months after orthotopic cardiac transplantation and in 3
normal subjects who were matched for age . End-organ
postsynaptic beta-adrenergic receptor chronotropic sensitiv-
ity of the SA node was evaluated by comparing the effect of
an intravenous infusion of isoproterenol on heart rate in
eight patients after transplantation and six normal subjects of
similar age .
Methods
Study groups .
Altogether, 31 cardiac transplant recipi-
ents and 9 normal subjects were studied
. Twenty-three
transplant recipients and 3 normal subjects underwent
exercise testing (Table 1) . Eight transplant recipients and six
normal subjects received a graded isoproterenol infusion
(Table ). All transplant recipients were clinically stable and
without histologic evidence of significant rejection at the
time of study
. Transplant recipients were classified into
those studied within 3 months of transplantation ("early
recipients" ; n = 11), and those studied more than 3 months
after transplantation ("late recipients" ; n = 1 ) . All trans-
plant recipients were receiving prednisone and cyclosporin
A, and four of the late recipients were also receiving
azothioprine
. The mean dose of cyclosporin A was 478 ± 40
mg/day (range 1 0 to 900
; median 480) . The mean dose of
prednisone was 5 mg/day (range 1
to 50; median 0 ± ) .
Serum potassium averaged 4
.4 ± 0.1 mEq/liter (range 3 .6 to
5.5 ; median 4 .3) and was similar in the early (4
.5 ± 0 .
mEq/liter) and late (4 .3 ± 0
.1 mEq/liter) recipients who
Table
. Characteristics of Six Normal Subjects and Eight Transplant Recipients Who Received an
Isoproterenol Infusion
Abbreviations as in Table 1 .
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underwent exercise testing and in the recipients who re-
ceived isoproterenol (4.4 ± 0 . mEq/liter) .
Normal subjects were healthy adults without a history of
significant cardiovascular disease . None were receiving
cardiac medications . Normal subjects were matched within 5
years to the age of each of the transplant recipients . This
study was approved by the Committee for the Protection of
Human Subjects from Research Risks of the Brigham and
Women's Hospital (March 11, 1987) . Informed consent was
obtained from all subjects .
Exercise protocol . Graded maximal exercise testing was
performed on a cycle ergometer (Sensormedics). Before
exercise, a short 18 gauge polyethylene cannula was inserted
into an antecubital vein and was kept open by a slow infusion
of 5% dextrose in water. Subjects rested in the supine
position for 30 min
. They then sat on the ergometer for 5 min
before pedaling at a rate of 60 rpm, starting at a work load of
10 to 30 W
. Exercise work load was increased every 3 min in
increments of 10 to 30 W in transplant recipients and in
increments of 30 W in normal subjects until peak exercise
was obtained, as defined by symptomatic fatigue or dyspnea,
or both, such that a pedaling rate of 60 rpm could not be
maintained .
Venous blood samples for plasma nonepinephrine and
epinephrine
were drawn with the patient at rest after sitting
on the cycle ergometer for 5 min and at the end of the peak
exercise level achieved
. Plasma nonepinephrine and epi-
nephrine concentrations were determined by radioenzymatic
assay as described by Peuler and Johnson
(4) .
Heart rate was monitored
by continuous electrocardio-
Normal Subjects
Transplant Recipients
No .
6
8
Age (yr)
31±3 36±5
Gender (M/F)
5/1
7/1
Age of transplanted heart (yr)
N/A ± 1
Time since transplantation (months) N/A
0 ± 3
Transplant Recipients
Normal Subjects Early Late
No . 3 11 1
Age (yr) 40+ 4
±4 45±3
Gender (M/F) 3/0 10/1 1 t/I
Age of transplanted heart (yr)
N/A ±
5±
Time since transplantation (months) N/A 1 .0 ± 0 .
13 ± I
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Table 3. Hemodynamic Responses to Exercise in 3 Normal Subjects and 3 Transplant Recipients
graphic (ECG) recording, and systolic blood pressure was
measured with use of a standard arm cuff mercury sphyg-
momanometer . Heart rate and systolic blood pressure were
recorded at rest, at the end of each work load and at peak
exercise. Subjects breathed through a three-way valve
mouthpiece connected to a metabolic cart (Sensormedics,
Horizon System) that allowed determinations of inspired
volumes, expired oxygen (0 ) and carbon dioxide (C0 )
content and respiratory quotient . Oxygen consumption
(V0 ) was recorded at rest, at the end of each work load and
at peak exercise. Respiratory quotient was recorded at peak
exercise .
Isoproterenol infusion . An intravenous cannula was in-
serted into an antecubital vein . After a 30 minute supine rest
period, isoproterenol was administered as a continuous
infusion by a Harvard pump at increasing rates every 5 min
as follows : 5, 10, 15, 0 and 5 ng/kg per min (5,6) . Heart rate
was monitored by means of a continuous ECG recording at
5 mm/min, and systolic and diastolic blood pressures were
measured with use of a standard arm cuff mercury sphyg-
momanometer . Heart rate and blood pressure were recorded
at rest and every 5 min during the last full minute of each
dose of isoproterenol . Isoproterenol infusion was discontin-
ued if heart rate increased by >35 beats/min or atrial or
ventricular ectopic activity developed . Venous blood sam-
ples for plasma nonepinephrine and epinephrine were drawn
at rest, just before isoproterenol infusion .
Normal subjects received isoproterenol infusions with
and without pretreatment with atropine on two different
days . Atropine (0 .01 to 0 .0 mg/kg, intravenous bolus) was
administered to abolish vagally mediated baroreflex slowing
of heart rate secondary to the effect of intravenous isopro-
terenol to widen pulse pressure (6,7) . Atropine was admin-
istered 3 to 5 min before isoproterenol infusion, and a stable
baseline heart rate was obtained for at least min before the
administration of isoproterenol .
Data analysis . Data were analyzed with use of nonpaired
or paired t tests, as appropriate . When more than two groups
*p
< 0.0167 versus normal subjects
: tp < 0
.0167 early versus late recipients . NS = not significant ;
V0, = oxygen consumption .
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were compared, Bonferroni's method for multiple compari-
sons was used, such that statistical significance was assumed
if the null hypothesis could be rejected at the 0 .05/n proba-
bility level, where n = the number of comparisons (8) . The
isoproterenol infusion rate that increased heart rate by 5
beats/min over baseline (Iso 5 ) was determined by linear
regression analysis (5) . All data are expressed as mean
values ± SEM .
Results
Exercise responses of normal subjects and transplant re-
cipients (Table 3, Fig. 1). Peak exercise work load and
oxygen consumption were significantly reduced in both early
and late transplant recipients . Early recipients tended to
have more impairment than late recipients . An adequate
exercise effort was apparent in all three groups, as reflected
by mean respiratory quotients of 1 . 3 ± 0 .0 , 1 .10 ± 0.04
and 1 .10 ± 0.03 in normal subjects and early and late
transplant recipients, respectively .
Heart rate at rest was higher in transplant recipients .
Peak exercise heart rate was reduced in transplant recipi-
ents, and the increment in heart rate from rest to peak
exercise was markedly depressed . The peak exercise incre-
ment in heart rate was more depressed in early than in late
recipients . Peak exercise systolic blood pressure and double
(rate-pressure) product were significantly reduced in both
early and late transplant recipients .
Changes in plasma catecholamines with exercise in normal
subjects and transplant recipients (Table 4, Fig . 1) . In early
transplant recipients, plasma nonepinephrine at rest and
during peak exercise and the increment from rest to peak
exercise were similar to those in normal subjects . In late
transplant recipients, plasma nonepinephrine at rest and
peak exercise and the increment from rest to peak exercise
were increased compared with those in normal subjects .
Plasma epinephrine at rest was mildly elevated in late
transplant recipients . In addition, epinephrine at peak exer-
Transplant Recipients
Normal Subjects Early Late p Value
Peak work load (W) 194 ± 7 66 ± 6* 105 ± 10* t
Peak VO, (ml/kg per min)
9 ± I
16±
* 19±
* NS
Heart rate (beats/min)
Baseline 69
±
85±3* 90±3* NS
Peak
173 -4 .
3
11 ± 6* 134 ± 3* NS
Change 104 ± 3 7 ± 5* 44 ± 3* t
Peak systolic blood 05 ± 5 149 ± 8* 166 ± 7* NS
pressure (mm Hg)
Peak double (rate-pressure) 35,46 ± 850 16,796 ± 1,693* 1,691 ± 1,95 * NS
product
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Figure 1 . Heart rate and plasma catecholamine levels at rest and
during peak exercise, and the increments from rest to peak exercise
in 3 normal subjects (dotted bars) and early and late transplant
recipients (hatched bars) . Data are the mean values ± SEM for 3
normal subjects and 11 early and 1 late transplant recipients
(described in Table 1) . *p < 0.0167 versus normal subjects .
cise and the increment with exercise were not different from
those in normal subjects, although both tended to be higher
in late recipients .
Effects of isoproterenol infusion (Table 5, Fig . ) . In
normal subjects, the isoproterenol infusion rate required to
increase heart rate by 5 beats/min (Iso 5) was 19 ± 4 ng/kg
per min . At the peak isoproterenol infusion rate, systolic
blood pressure increased, diastolic blood pressure decreased
and pulse pressure increased substantially by 47 ± 6 mm Hg .
It has been shown previously (6) that continuous graded
isoproterenol infusion causes significant vagal inhibition of
Table 4 . Catecholamine Responses to Exercise in 3 Normal Subjects and 3 Transplant Recipients
*p <
0 .0167 versus normal subjects . NS = not significant .
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heart rate, presumably because of the effect of an increase in
pulse pressure to stimulate baroreflex activity . Because the
heart in transplant recipients lacks vagal innervation, it was
important to eliminate the influence of vagal tone in normal
subjects . Pretreatment with atropine caused an increase in
basal heart rate, and was associated with a greater increase
in heart rate at each isoproterenol infusion rate (Fig . ), as
reflected by a significant decrease in the IS0 5 to 9 ± ng/kg
per min .
In transplant recipients, rest heart rate (88 ± 5 beats/min)
was similar to that in atropine-treated normal subjects (93 ±
5 beats/min) . Likewise, the heart rate response to isoproter-
enol was similar to that in atropine-treated normal subjects,
with an Iso, 5 of 11 ± 1 versus 9 ± ng/kg per min in normal
subjects .
Discussion
These data confirm that peak exercise capacity is signif-
icantly reduced in clinically stable cardiac transplant recip-
ients several months after operation, and they emphasize
that there is a substantial attenuation in the peak heart rate
response to a maximal exercise effort (1) . This is apparent
from the reduction in peak exercise heart rate, and is even
more evident when the incremental increase in heart rate
with exercise is examined. For instance, heart rate increased
by 104 beats/min during exercise in normal subjects, but by
only 7 and 44 beats/min, respectively, in patients early and
late after cardiac transplantation .
Response of circulating catecholamines to exercise . The
primary goal of these studies was to clarify the mechanism
responsible for this attenuated peak heart rate response in
transplant recipients . Because the heart of these patients is
surgically denervated, the local delivery of nonepinephrine
to the sinoatrial (SA) node by sympathetic nerves is substan-
tially reduced or completely absent . Therefore, it can be
reasonably assumed that beta-adrenergic receptor stimula-
tion of the SA node is solely due to circulating plasma
nonepinephrine and epinephrine . In transplant recipients,
the peak levels and the incremental increases in nonepineph-
Transplant Recipients
Normal Subjects Early Late p Value
Plasma norepinephrine (pg/ml)
Baseline 55 ± 15 3 4 ± 59 45 ± 53* NS
Peak 1,653 ± 11 1,97 ± 347 ,886 ± 5* NS
Change 1 .398 ± 11 1,648 ± 34 ,434 ± 60* NS
Plasma epinephrine (pg/ml)
Baseline 17 ± 4 NS37±10 44+3*
Peak 6 ± 5 1 ± 53 366 ± 10 NS
Change
44 ± 5 17 ± 45 3 ± 10
NS
34
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0
Table 5 . Effects of Isoproterenol (ISO 5 ) Infusion in Six Normal Subjects and Eight
Transplant Recipients
*p < 0
.0167 versus normal subjects without atropine pretreatment
; tp < 0
.0167 versus normal subjects with
atropine pretreatment .
rine and epinephrine with exercise were either comparable
with or greater than those in normal subjects . Thus, these
Figure . The increase in heart rate at rest in response to a
continuous graded infusion of isoproterenol in normal subjects (open
circles), normal subjects pretreated with atropine (closed circles) and
transplant recipients (squares) . Data are mean values ± SEM for six
normal subjects and eight transplant recipients (described in Table
) . Atropine pretreatment in normal subjects caused a significant
decrease in the mean 150 5 dose from 19 ± 4 to 9 ± ng/kg per min
(p < 0.0167) . The mean Iso 5 doses in atropine-treated normal
subjects and transplant recipients were similar (9 ± and 11 ± 1
ng/kg per min, respectively) . Iso 5 = isoproterenol infusion rate that
increased heart rate by 5 beats/min over baseline .
5
	
10 15 0 5
Isoprotereno/ Infusion Rate (ng/kg/min)
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data do not suggest an impairment in the circulating cate-
cholamine response to peak exercise . On the contrary, they
suggest that the sympathetic response to peak exercise may
actually be mildly increased in late transplant recipients .
There is relatively little information available regarding
the relation between circulating catecholamine levels and
heart rate in normal subjects . Recently, Stratton et al . (9)
studied the hemodynamic effects of the concurrent infusion
of nonepinephrine and epinephrine in atropine-treated nor-
mal subjects . This approach achieved plasma norepineph-
rine and epinephrine levels of 1,78 and 355 pg/ml, respec-
tively, and resulted in an increase in heart rate to 1 7
beats/min. The denervated transplanted heart provides a
unique opportunity to evaluate the relation between circu-
lating catecholamine levels and heart rate during exercise . In
our study, plasma catecholamines at peak exercise reached
levels similar to those achieved by Stratton et al . (9) with
intravenous catecholamine infusion, and were associated
with a peak heart rate of 11 and 134 beats/min in early and
late recipients, respectively . Taken together with the data of
Stratton et al . (9), our observations suggest that the heart
rate response to exercise in transplant recipients is commen-
surate with and probably appropriate for the levels of
circulating catecholamines . Presumably, the heart rate re-
sponse in normal subjects is higher for any given circulating
catecholamine level because of the additional effect of direct
efferent innervation .
Postsynaptic beta-adrenergic responsiveness . There is sub-
stantial in vitro documentation (10-1 ) of an inverse relation
between the level of beta-adrenergic receptor stimulation
and the responsiveness of the beta-adrenergic receptor path-
way. Persistently increased beta-adrenergic stimulation is
Normal Subjects
Without
Atropine
With
Atropine Transplant Recipients
Basal heart rate (beats/min) 63 ± 7 93±5* 88±5*
IS0 5 (ng/kg per min) 19 ± 4 9± * 11±1*
Systolic blood pressure (mm Hg)
Baseline 106 ± 5 110 ± 4 136 ± 6*t
Peak infusion 140 ± 8 13 ±5 145±6
Change
+35 ± 6 + 3 ± 6 +9 ± 5*
Diastolic blood pressure (mm Hg)
Baseline
70 ± 3
68 ± 1 91 ± 6*t
Peak infusion 58 ± 3 57±3 80±5*t
Change -11 ± 3 -11±3 -1 ±4
Pulse pressure (mm Hg)
Baseline 37 ± 4 4 ±5 45±3
Peak infusion 8
± 7
76±3 65±7
Change +47 ± 6 +34 ± 5 + 1 ± 8*
JACC Vol . 14, No .
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associated with decreased responsiveness of the beta-
adrenergic pathway and decreased density of myocardial
beta-adrenergic receptors (10-1
)
. Conversely, it has been
shown in an animal model of sympathetic cardiac denerva-
tion that there is an increase in beta-adrenergic receptor
density, which may be associated with supersensitivity to
beta-adrenergic agonists (13,14) . More recently, Yusuf et al .
(5) observed that the chronotropic response to isoproterenol
infusion in cardiac transplant recipients was increased com-
pared with that in normal subjects
. Based on this observa-
tion, it was postulated that cardiac transplant recipients
would exhibit an increase in beta-adrenergic receptor den-
sity (5) .
If postsynaptic beta-adrenergic supersensitivity of the SA
node occurred after cardiac transplantation, it might play an
important role in compensating for the lack of direct sympa-
thetic efferent nerves to the heart . To assess postsynaptic
beta-adrenergic responsiveness in the SA node directly, we
evaluated the chronotropic response to graded infusions of
isoproterenol . Because the transplanted heart is without
direct vagal tone, it was important to block vagal tone in the
normal subjects for comparison . Arnold and McDevitt (6)
previously showed that isoproterenol administration by the
graded continuous infusion method used in this study is
associated with increased vagal tone and attenuation of the
chronotropic response to isoproterenol in normal subjects .
Presumably the increase in pulse pressure stimulates barore-
ceptors, thereby leading to sympathetic withdrawal and
increased vagal tone . As anticipated from the foregoing
discussion, in normal subjects, preinfusion of atropine re-
sulted in a significant increase in the chronotropic response
to isoproterenol, such that at any given infusion rate of
isoproterenol, the heart rate increase was greater with atro-
pine
. The chronotropic response to isoproterenol of trans-
plant recipients was similar to that in atropine-treated nor-
mal subjects (Fig . )
. Thus, we found no evidence of
postsynaptic beta-adrenergic receptor supersensitivity or
subsensitivity in transplant recipients . This conclusion is
similar to that reached by Gilbert et al . (15) .
A finding of normal beta-adrenergic receptor sensitivity
in transplanted hearts is consistent with recent observations
(15,16) that beta-adrenergic receptor density is normal or
slightly reduced in transplanted human myocardium . Fur-
thermore, Denniss et al . (16) found that the isoproterenol-
stimulated increments in adenylate cyclase activity are sim-
ilar in normal and transplanted myocardium . Thus, the
biochemical observations in transplanted myocardium are
consistent with our physiologic data, and together strongly
suggest that the sensitivity of the beta-adrenergic pathway in
transplanted human myocardium is normal .
Our conclusion regarding the chronotropic response to
isoproterenol infusion in normal subjects differs from that of
Yusuf et al . (5), who studied the chronotropic response to a
graded isoproterenol infusion without atropine pretreatment .
Because in the absence of atropine pretreatment the chro-
notropic response to isoproterenol in our normal subjects
was very similar to that reported by Yusuf et al . (5) (Fig . ),
it appears that the apparent supersensitivity in transplant
recipients studied by those investigators may have been due
to the effect of vagal tone to attenuate the heart rate response
to isoproterenol in normal subjects .
Conclusions . These observations suggest that the attenu-
ated heart rate response to exercise in patients after cardiac
transplantation is primarily due to lack of direct sympathetic
innervation of the SA node. The circulating catecholamine
response to exercise is normal or slightly augmented, and the
end-organ response to beta-adrenergic stimulation appears
to be normal .
We thank Gilbert H . Mudge, Jr ., MD, Pia Young, RN and the other members
of the Cardiac Transplantation Service at the Brigham and Women's Hospital
for their help, without which this work would not have been possible .
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